Euro Optometry 2019 Vienna, Austria August 22-23, 2019

Know more about: Ophthalmogenetics and Gene Therapy:
Ophthalmic hereditary qualities are worried about the hereditary commitment to ophthalmic illness, including assurance of examples and dangers of legacy, and in addition finding, visualization, and advancement of medications for hereditary variations from the norm.
The advances in gene therapy maintain extensive promise for the cure of ophthalmic conditions. Gene therapy is additionally in a position to deal with primary open-angle glaucoma (POAG) in animal models, and research show it is economically viable.

Genes may additionally be delivered into cells in vitro or in vivo making use of viral or non-viral vectors. Recent technical advances have led to the demonstration of the molecular basis of a range of ocular diseases.

For more details contact:
Navye Sharon
Program Manager | Euro Optometry 2018
47 Churchfield Road
London, W3 6AY, UK
Phone:+448000148923
Fax: +442030041517
E optometry@ophthalmologyconferences.com